• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

自身免疫性肺泡蛋白沉积症合并新型冠状病毒肺炎一例报告:与时俱进的关联!

A case report of Covid-19 in an autoimmune pulmonary alveolar proteinosis: An association in tune with the times!

作者信息

Coirier Valentin, Delamaire Flora, Chauvin Pierre, Kerjouan Mallorie, Lederlin Mathieu, Maamar Adel, Jouneau Stéphane

机构信息

Department of Infectious Diseases and Intensive Care, Rennes University Hospital, Rennes, France.

Department of Respiratory Diseases, Rennes University Hospital, Rennes, France.

出版信息

Respir Med Case Rep. 2023;42:101825. doi: 10.1016/j.rmcr.2023.101825. Epub 2023 Feb 27.

DOI:10.1016/j.rmcr.2023.101825
PMID:36874265
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9969748/
Abstract

Autoimmune pulmonary alveolar proteinosis (PAP) is a rare disease characterized by the alveoli accumulation of surfactants proteins and lipids, which diagnosis is confirmed by the presence of GM-CSF antibodies in serum. PAP can be evoked when its characteristic images on chest computed-tomography (CT) are present: bilateral and multifocal ground-glass opacities and crazy-paving appearance. Patients with PAP are at an increased risk of opportunistic infections caused by Nocardia, mycobacteria and fungal pathogens due to impaired processing of pulmonary surfactant. We here report a typical case of newly diagnosed autoimmune PAP, with initial indication to realize a whole-lung lavage. Despite this treatment the patient presented a marked clinical worsening, with increasing need for oxygen and finally the need for mechanical ventilation. The chest CT was controlled and found to be typical of PAP, while the search for opportunistic infections remained negative. Finally, SARS-CoV-2 PCR was performed on bronchoalveolar lavage fluid, and was positive, whereas it had previously been negative twice. Our case report highlights the difficulty of distinguishing SARS-CoV-2 infection in the context of PAP, as the chest CT features are similar. We believe that a SARS-CoV-2 RT-PCR should be systematically realized in case of respiratory deterioration in PAP patients.

摘要

自身免疫性肺泡蛋白沉积症(PAP)是一种罕见疾病,其特征为肺泡内表面活性物质蛋白和脂质蓄积,血清中GM-CSF抗体的存在可确诊该病。当胸部计算机断层扫描(CT)出现其特征性影像时可诱发PAP:双侧多灶性磨玻璃影及铺路石样表现。由于肺表面活性物质处理受损,PAP患者发生诺卡菌、分枝杆菌和真菌病原体所致机会性感染的风险增加。我们在此报告一例新诊断的自身免疫性PAP典型病例,最初的治疗方案是进行全肺灌洗。尽管进行了该治疗,患者的临床症状仍显著恶化,对氧气的需求增加,最终需要机械通气。复查胸部CT符合PAP表现,而机会性感染检查结果为阴性。最后,对支气管肺泡灌洗液进行了SARS-CoV-2聚合酶链反应(PCR)检测,结果呈阳性,而此前两次检测均为阴性。我们的病例报告强调了在PAP背景下区分SARS-CoV-2感染的困难,因为胸部CT特征相似。我们认为,PAP患者出现呼吸恶化时应常规进行SARS-CoV-2逆转录PCR检测。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/baa1/9996343/aafb79fed0a0/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/baa1/9996343/aafb79fed0a0/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/baa1/9996343/aafb79fed0a0/gr1.jpg

相似文献

1
A case report of Covid-19 in an autoimmune pulmonary alveolar proteinosis: An association in tune with the times!自身免疫性肺泡蛋白沉积症合并新型冠状病毒肺炎一例报告:与时俱进的关联!
Respir Med Case Rep. 2023;42:101825. doi: 10.1016/j.rmcr.2023.101825. Epub 2023 Feb 27.
2
Combined-modality therapy for pulmonary alveolar proteinosis in a remote setting: a case report.偏远地区肺泡蛋白沉积症的联合治疗模式:一例报告。
BMC Pulm Med. 2019 Mar 12;19(1):61. doi: 10.1186/s12890-019-0822-x.
3
Pulmonary alveolar proteinosis.肺泡蛋白沉积症。
Semin Respir Crit Care Med. 2012 Oct;33(5):498-508. doi: 10.1055/s-0032-1325160. Epub 2012 Sep 21.
4
Post-COVID-19 Pulmonary Alveolar Proteinosis Treated Successfully with Whole Lung Lavage: A Rare Case Report.全肺灌洗成功治疗新型冠状病毒肺炎后并发的肺泡蛋白沉积症:1例罕见病例报告
Pulm Ther. 2023 Jun;9(2):287-293. doi: 10.1007/s41030-023-00224-0. Epub 2023 May 11.
5
Elevated Serum Anti-GM-CSF Antibodies before the Onset of Autoimmune Pulmonary Alveolar Proteinosis in a Patient with Sarcoidosis and Systemic Sclerosis.结节病和系统性硬化症患者自身免疫性肺泡蛋白沉积症发病前血清抗GM-CSF抗体升高。
Tohoku J Exp Med. 2017 Sep;243(1):77-83. doi: 10.1620/tjem.243.77.
6
Autoimmune pulmonary alveolar proteinosis: clinical course and diagnostic criteria.自身免疫性肺肺泡蛋白沉积症:临床经过和诊断标准。
Autoimmun Rev. 2014 Apr-May;13(4-5):513-7. doi: 10.1016/j.autrev.2014.01.046. Epub 2014 Jan 11.
7
Pulmonary alveolar proteinosis.肺泡蛋白质沉积症。
Respirology. 2020 Aug;25(8):816-826. doi: 10.1111/resp.13831. Epub 2020 May 3.
8
Sirolimus-induced secondary pulmonary alveolar proteinosis.西罗莫司诱导的继发性肺泡蛋白沉积症。
Respir Med Case Rep. 2021 Dec 15;35:101566. doi: 10.1016/j.rmcr.2021.101566. eCollection 2022.
9
Pulmonary Alveolar Proteinosis due to Familial Myelodysplastic Syndrome with resolution after stem cell transplant.家族性骨髓增生异常综合征所致肺泡蛋白沉积症,干细胞移植后病情缓解
Autops Case Rep. 2022 May 13;12:e2021382. doi: 10.4322/acr.2021.382. eCollection 2022.
10
Pulmonary alveolar proteinosis - a crazy presentation of dyspnea.肺泡蛋白沉积症——一种呼吸困难的奇特表现。
Eur Clin Respir J. 2018 Dec 4;6(1):1552065. doi: 10.1080/20018525.2018.1552065. eCollection 2019.

引用本文的文献

1
Cause of Death Analysis in a 9½-Year-Old with COVID-19 and Dravet Syndrome.一名9岁半的新冠病毒病(COVID-19)合并德雷维特综合征患儿的死因分析
Pathophysiology. 2025 Jan 10;32(1):3. doi: 10.3390/pathophysiology32010003.
2
Effects of COVID-19 infection in patients with autoimmune pulmonary alveolar proteinosis: a single-center study.COVID-19 感染对自身免疫性肺泡蛋白沉积症患者的影响:一项单中心研究。
Orphanet J Rare Dis. 2023 Nov 11;18(1):353. doi: 10.1186/s13023-023-02950-9.

本文引用的文献

1
COVID-19 in patients with pulmonary alveolar proteinosis: a European multicentre study.肺泡蛋白沉积症患者的新型冠状病毒肺炎:一项欧洲多中心研究
ERJ Open Res. 2023 Jan 3;9(1). doi: 10.1183/23120541.00199-2022. eCollection 2023 Jan.
2
Quantifying the contribution of pathways of nosocomial acquisition of COVID-19 in English hospitals.量化 COVID-19 在英国医院获得的途径对医院感染的贡献。
Int J Epidemiol. 2022 May 9;51(2):393-403. doi: 10.1093/ije/dyab241.
3
The Usefulness of Chest CT Imaging in Patients With Suspected or Diagnosed COVID-19: A Review of Literature.
胸部 CT 成像在疑似或确诊 COVID-19 患者中的应用:文献复习。
Chest. 2021 Aug;160(2):652-670. doi: 10.1016/j.chest.2021.04.004. Epub 2021 Apr 20.
4
Chest CT in COVID-19 pneumonia: A review of current knowledge.胸部 CT 在 COVID-19 肺炎中的应用:现有知识综述。
Diagn Interv Imaging. 2020 Jul-Aug;101(7-8):431-437. doi: 10.1016/j.diii.2020.06.001. Epub 2020 Jun 11.
5
Pulmonary alveolar proteinosis.肺泡蛋白质沉积症。
Respirology. 2020 Aug;25(8):816-826. doi: 10.1111/resp.13831. Epub 2020 May 3.
6
Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study.中国武汉 99 例 2019 年新型冠状病毒肺炎患者的流行病学和临床特征:描述性研究。
Lancet. 2020 Feb 15;395(10223):507-513. doi: 10.1016/S0140-6736(20)30211-7. Epub 2020 Jan 30.
7
Formal guidelines: management of acute respiratory distress syndrome.正式指南:急性呼吸窘迫综合征的管理
Ann Intensive Care. 2019 Jun 13;9(1):69. doi: 10.1186/s13613-019-0540-9.
8
Pulmonary alveolar proteinosis.肺泡蛋白沉积症。
Nat Rev Dis Primers. 2019 Mar 7;5(1):16. doi: 10.1038/s41572-019-0066-3.
9
Acute respiratory distress syndrome: the Berlin Definition.急性呼吸窘迫综合征:柏林定义。
JAMA. 2012 Jun 20;307(23):2526-33. doi: 10.1001/jama.2012.5669.
10
Opportunistic infections in patients with pulmonary alveolar proteinosis.肺肺泡蛋白沉积症患者的机会性感染。
J Infect. 2012 Aug;65(2):173-9. doi: 10.1016/j.jinf.2012.03.020. Epub 2012 Apr 4.